Plasma Methionine Sulfoxide in Persons with Familial Alzheimer’s Disease Mutations
Dementia and Geriatric Cognitive Disorders, 05/24/2012
Ringmana JM et al. – The data provide evidence for elevated MetO levels in persons carrying familial Alzheimer’s disease (AD) (FAD) mutations that correlate with other indices of oxidative stress and suggest that plasma oxidative stress markers may be useful for diagnosis of AD.



